|
1
|
Saito T, Mitomi H, Kurisaki A, Torigoe T,
Takagi T, Suehara Y, Okubo T, Kaneko K and Yao T: Low-grade
myofibroblastic sarcoma of the distal femur. Int J Surg Case Rep.
4:195–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roth TM, Fratkin J, Woodring TC and
McGehee RP: Low-grade myofibroblastic sarcoma of the vulva. Gynecol
Oncol. 92:361–364. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miguel San P, Fernández G, Ortiz-Rey JA
and Larrauri P: Low-grade myofibroblastic sarcoma of the distal
phalanx. J Hand Surg Am. 29:1160–1163. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamada T, Yoshimura T, Kitamura N, Sasabe
E, Ohno S and Yamamoto T: Low-grade myofibroblastic sarcoma of the
palate. Int J Oral Sci. 4:170–173. 2013. View Article : Google Scholar
|
|
5
|
Gabbiani G, Ryan GB and Majne G: Presence
of modified fibroblasts in granulation tissue and their possible
role in wound contraction. Experientia. 27:549–550. 1971.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Follonier L, Schaub S, Meister JJ and Hinz
B: Myofibroblast communication is controlled by intercellular
mechanical coupling. J Cell Sci. 121:3305–3316. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mentzel T: Low-grade myofibroblastic
sarcomaFletcher CDM, Bridge JA, Hogendoorn PCW and Mertens F: World
Health Organization Classification of Tumours: Pathology and
genetics of tumours of soft tissue and bone. IARC Press; Lyon,
France: pp. 85–86. 2013
|
|
8
|
Fujii S, Shinjo K, Matsumoto S, Harada T,
Nojima S, Sato S, Usami Y, Toyosawa S, Morii E, Kondo Y and Kikuchi
A: Epigenetic upregulation of ARL4C, due to DNA hypomethylation in
the 3′-untranslated region, promotes tumorigenesis of lung squamous
cell carcinoma. Oncotarget. 7:81571–81587. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kurihara S, Oda Y, Ohishi Y, Kaneki E,
Kobayashi H, Wake N and Tsuneyoshi M: Coincident expression of
beta-catenin and cyclin D1 in endometrial stromal tumors and
related high-grade sarcomas. Mod Pathol. 23:225–234. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nishijima T, Yamamoto H, Nakano T,
Nakashima T, Taguchi K, Masuda M, Motoshita J, Komune S and Oda Y:
Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis
of carcinoma ex pleomorphic adenoma. Hurn Pathol. 46:1730–1443.
2015.
|
|
11
|
Fujita K, Yamamoto H, Matsumoto T,
Hirahashi M, Gushima M, Kishimoto J, Nishiyama K, Taguchi I, Yao T
and Oda Y: Sessile serrated adenoma with early neoplastic
progression: A clinicopathologic and molecular study. Am J Surg
Pathol. 35:295–304. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oda Y, Sakamoto A, Saito T, Kawauchi S,
Iwamoto Y and Tstuneyoshi M: Molecular abnormalities of p53, MDM2,
and H-ras in synovial sarcoma. Mod Pathol. 13:994–1004. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Demarosi F, Bay A, Moneghini L and
Carrassi A: Low-grade myofibroblastic sarcoma of the oral cavity.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 108:248–254.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tomasek JJ, Gabbianr G, Hinz B, Chaponnier
C and Brown RA: Myofibroblasts and mechano-regulation of connective
tissue remodelling. Nat Rev Mol Cell Biol. 3:349–363. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Niedzielska I, Janic T and Mrowiec B:
Low-grade myofibroblastic sarcoma of the mandible: A case report. J
Med Case Rep. 3:84582009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Erickson-Johnson MR, Chou MM, Evers BR,
Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X and Oliveira AM:
Nodular fasciitis: A novel model of transient neoplasia induced by
MYH9-USP6 gene fusion. Lab Invest. 91:1427–1433. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kohashi K, Oda Y, Yamamoto H, Tamiya S,
Matono H, Iwamoto Y, Taguchi T and Tsuneyoshi M: Reduced expression
of SMARCB1/INI1 protein in synovial sarcoma. Mod Pathol.
23:981–990. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee PJ, Yoo NS, Hagemann IS, Pfeifer JD,
Cottrell CE, Abel HJ and Duncavage EJ: Spectrum of mutations in
leiomyosarcomas identified by clinical targeted next-generation
sequencing. Erp Mol Pathol. 102:156–161. 2017. View Article : Google Scholar
|
|
19
|
Overholtzer M, Rao PH, Favis R, Lu XY,
Elowitz MB, Barany F, Ladanyi M, Gorlick R and Levine AJ: The
presence of p53 mutations in human osteosarcomas correlates with
high levels of genomic instability. Proc Natl Acad Sci USA.
100:11547–11552. 2003. View Article : Google Scholar : PubMed/NCBI
|
